Interstitial photodynamic therapy with the second-generation photosensitizer bacteriochlorin a in a rat model for liver metastases
1998

Using Bacteriochlorin A for Liver Tumor Treatment

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): JP Rovers, JJ Schuitmaker, AL Vahrmeijer, JH van Dierendonck, OT Terpstra

Primary Institution: Leiden University Medical Centre

Hypothesis

Can interstitial photodynamic therapy with bacteriochlorin A effectively treat liver metastases in a rat model?

Conclusion

The study suggests that optimal results in interstitial photodynamic therapy for liver tumors with bacteriochlorin A are achieved shortly after administration.

Supporting Evidence

  • Bacteriochlorin A concentrations in liver and tumor tissue were highest 1 hour after administration.
  • Illumination 1 hour after BCA administration resulted in the largest lesions.
  • More than 95% of tumor tissue showed necrosis 2 days after treatment.
  • Islands of vital-looking tumor cells were observed in all treated animals.
  • Serum ALAT and ASAT levels increased significantly after treatment.

Takeaway

This study tested a new treatment for liver tumors using a special light and a drug called bacteriochlorin A, which helps destroy tumors when exposed to light.

Methodology

Male Wag/Rij rats were used to test the effects of interstitial photodynamic therapy with bacteriochlorin A, measuring lesion sizes and BCA concentrations at various time points.

Limitations

The study observed tumor regrowth despite high levels of necrosis, indicating that complete tumor destruction was not achieved.

Participant Demographics

Male Wag/Rij rats weighing 245-315 g were used in the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication